NEDD9 rs760678 polymorphism and the risk of Alzheimer's disease: A meta-analysis

Neuroscience Letters

Volumn 527, Issue 2, 2012, Pages 121-125

  Wang, Yucheng ^a   Bi, Liqing ^a   Wang, Hui ^b   Li, Yanyan ^a   Di, Qun ^a   Xu, Wei ^a   Qian, Yun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Alzheimer's disease; Developmentally downregulated 9; Meta analysis; Neural precursor cell expressed; Polymorphism

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; NEDD9 PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASIAN; CAUCASIAN; ETHNICITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HOMOZYGOSITY; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK ASSESSMENT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; RISK;

EID: 84866749044     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.044     Document Type: Article

References (22)

1. Aquino J.B., Lallemend F., Marmigère F., Adameyko I.I., Golemis E.A., Ernfors P. The retinoic acid inducible Cas-family signaling protein Nedd9 regulates neural crest cell migration by modulating adhesion and actin dynamics. Neuroscience 2009, 162:1106-1119.
2. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. Journal of Clinical Epidemiology 2003, 56:297-303.
3. Bargon S.D., Gunning P.W., O'Neill G.M. The Cas family docking protein, HEF1, promotes the formation of neurite-like membrane extensions. Biochimica et Biophysica Acta 2005, 1746:143-154.
4. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. Apo-E and age of onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997, 48:139-147.
5. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
6. Chapuis J., Moisan F., Mellick G., Elbaz A., Silburn P., Pasquier F., Hannequin D., Lendon C., Campion D., Amouyel P., Lambert J.C. Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. Human Molecular Genetics 2008, 17:2863-2867.
7. Cochran W.G. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968, 24:295-313.
8. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188.
9. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629-634.
10. Fu Y., He F., Tang N.L., Tam C.W., Lui V.W., Chiu H.F., Lam L.C. NEDD9 gene polymorphism influences the risk of Alzheimer disease and cognitive function in Chinese older persons. Alzheimer Disease and Associated Disorders 2012, 26:88-90.
11. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry 2006, 63:168-174.
12. Lawson M.A., Whyte D.B., Mellon P.L. GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene. Cellular and Molecular Biology 1996, 16:3596-3605.
13. Li Y., Grupe A., Rowland C., Holmans P., Segurado R., Abraham R., Jones L., Catanese J., Ross D., Mayo K., Martinez M., Hollingworth P., Goate A., Cairns N.J., Racette B.A., Perlmutter J.S., O'Donovan M.C., Morris J.C., Brayne C., Rubinsztein D.C., Lovestone S., Thal L.J., Owen M.J., Williams J. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics 2008, 17:759-767.
14. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959, 22:719-748.
15. Sasaki T., Iwata S., Okano H.J., Urasaki Y., Hamada J., Tanaka H., Dang N.H., Okano H., Morimoto C. Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia. Stroke 2005, 36:2457-2462.
16. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
17. Tedde A., Bagnoli S., Piaceri I., Lucenteforte E., Bessi V., Bracco L., Mugelli A., Sorbi S., Nacmias B. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease. Neuroscience Letters 2010, 477:121-123.
18. Thakkinstian A., McElduff P., D'Este C., Duffy D., Attia J. A method for meta-analysis of molecular association studies. Statistics in Medicine 2005, 24:1291-1306.
19. Querfurth H.W., LaFerla F.M. Alzheimer's disease. New England Journal of Medicine 2010, 362:329-344.
20. Vogel T., Ahrens S., Büttner N., Krieglstein K. Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component. Cerebral Cortex 2010, 20:661-671.
21. Xing Y.Y., Yu J.T., Yan W.J., Chen W., Zhong X.L., Jiang H., Wang P., Tan L. NEDD9 is genetically associated with Alzheimer's disease in a Han Chinese population. Brain Research 2011, 1369:230-234.
22. Zhang J., Zhang Y., Jin J., Li M., Xie K., Wen C., Cheng R., Chen C., Lu The J. The-1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis. Cytokine 2011, 56:351-355.